Crispr Therapeutics Trade Review: How We Scored A Huge 24% Gain In Just 2 Days

$CRSP breakout trade

We recently locked in a cool gain of +24% with a 2-day swing trade in Crispr Therapeutics (CRSP). Continue reading this educational trade walk-through to find out exactly how we did it!

One of our favorite scans in TC2000 looks for stocks with explosive price gains of 20% or more, over a five-day period, accompanied by greater than average volume.

Volume surges are the classic footprint of mutual funds, hedge funds, and other institutions and indicate institutional accumulation.

As such, volume is one of the best and most reliable technical indicators–the bigger the volume surge, the better.

Many stocks that have already broken out on massive volume are too extended to purchase without some price consolidation.

However, high volume breakouts tell us a stock should be “in play” after a short-term pause or pullback.

With a little patience to wait for a low-risk entry point, traders can score huge gains on the next wave up in breakout stocks.

That’s how we recently locked in a +24% gain on a 2-day swing trade in Crispr Therapeutics (CRSP), which is clearly detailed below.

The Low-Risk Buy Setup

CRSP first caught our attention while screening stocks with TC2000 in late October.

The daily chart of CRSP below shows the swing trade setup prior to the buy entry in our nightly newsletter:


The massive, high-volume thrust off the lows put the price of CRSP back above all major moving averages and intermediate-term downtrend line.

After chopping around on declining volume for a few days, a tight trading range with inside days developed on November 7 and 11.

Notice how the price also remained above the rising 10-day moving average (teal line)–an excellent confirmation of short-term strength.

In The Wagner Daily, our nightly swing trading report, we set a buy stop order above the November 8 high as the entry trigger.

The First Buy Entry – Ahead Of The Crowd

1 2
View single page >> |

Disclaimer: Past results are not necessarily indicative of future results. There is a high degree of risk for substantial losses in trading securities. All data and material on this website and/or ...

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.